glioma
-
July 28, 2021
Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma Bookmark
George Lundberg, MDOncolytic viruses may offer serious hope as a very new type of treatment for malignant glioma. As reported by OncLive, the oncolytic virus teserpaturev was recently approved in Japan after a phase 2 clinical trial.
.
.
-
August 15, 2020
Intraoperative MRI Versus 5-ALA in High-Grade Glioma Resection: A Network Meta-Analysis Bookmark
George Lundberg, MDResearch paper from the Journal of Neurosurgery curated by Editor in Chief George Lundberg, MD, who notes:
The extent of tumor resection—how much of the tumor is able to be removed—at the initial surgery is probably the most important factor in prognosis of glioblastoma. This academic research paper explores methods that help surgeons maximize tumor removal.
Go to full paper published in the Journal of Neurosurgery.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice Bookmark
George Lundberg, MDResearch paper from the Journal of Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:
Safety and potential adverse effects are serious issues with many cancer treatments. This academic paper outlines post-marketing research that reveals few adverse effects from a type of treatment known as tumor-treating fields (TTF) in brain malignancies.
Go to full paper published in the Journal of Neuro-Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease Bookmark
George Lundberg, MDResearch paper from Cancers curated by Editor in Chief George Lundberg, MD, who notes:
Instead of focusing on “curing” cancer, the authors of this academic research paper focus on approaches to managing cancer as a chronic disease.
Go to full paper published in Cancers.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 14, 2020
A Systematic Review of Tumor Treating Fields Therapy for High-Grade Gliomas Bookmark
George Lundberg, MDResearch paper from Journal of Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes:
Tumor-treating fields (TTF) is a type of cancer treatment that uses alternating electric pulses. Its use for adults with high-grade gliomas remains controversial, and as outlined in this academic review paper, more high-quality research is needed.
Go to full paper published in Journal of Neuro-Oncology.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
October 1, 2019
Diagnostic Testing for Diffuse Gliomas Bookmark
George Lundberg, MDAnnouncement from the College of American Pathologists curated by Editor in Chief George Lundberg, MD, who notes:
What forms of testing should be done for diffuse gliomas? In this announcement, a global panel invites comments about proposals.
Go to full announcement published by the College of American Pathologists.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
August 9, 2019
Brainstem Gliomas Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD:
A brainstem glioma is a very serious disease that is rare and mostly affects children. Diffuse pontine intrinsic glioma (DPIG) is one type of brainstem glioma. For an authoritative, up-to-date, detailed, comprehensive, and unbiased overview of brainstem gliomas, check out this presentation and discussion. (You may be required to register for free to view it.)
-
August 9, 2019
Glioblastoma Multiforme (GBM) Bookmark
George Lundberg, MDCurated by Editor in Chief George Lundberg, MD:
Most malignant brain tumors are gliomas, which begin in nerve-supporting cells known as glial cells. “Glioblastoma multiforme (GBM) is the most common and most malignant of the glial tumors,” according to this comprehensive presentation about GBM. Check it out for an authoritative, up-to-date, detailed, unbiased perspective. (You may be required to register for free to view the presentation.)
-
March 7, 2019
Researchers Tap Genomic Technology to Develop Personalized Treatments for Pediatric Glioma Bookmark
Emma Shtivelman, PhDExcerpt:
“Researchers at UCSF Benioff Children’s Hospitals are using next-generation genomic technology to develop targeted therapies for high-grade pediatric glioma.
“Sabine Mueller, MD, PhD, adjunct associate professor of neurology, pediatrics and neurosurgery at University of California, San Francisco, and colleagues aim to treat as many as 44 children and young adults with this disease.”
Go to full article published by Healio on Feb 3, 2019.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
-
September 6, 2018
Patient Foundation Collaboration to Advance ONC201 in DIPG and other H3 K27M-mutant Gliomas
Musella Foundation, Cancer Commons, xCures and Oncoceutics announced the initiation of a collaboration to develop ONC201 as a new treatment for diffuse intrinsic pontine glioma (DIPG) and other H3 K27M-mutant gliomas. Critical to the collaboration is $1M in funding from The Musella Foundation, Michael Mosier Defeat DIPG Foundation and The Cure Starts Now Foundation. Cancer Commons and xCures will contribute additional resources to the… Read more »